Challenging Cases in Skin of Color Patients
This year at the 17th Annual Dermatology, Aesthetic & Surgical Conference (ODAC), Dr Amy McMichael presented the audience with new pearls of advice on how to approach and diagnose complex medical dermatology cases in patients with skin of color. During her session, she addressed the important need for providers to be able to recognize disease in patients of all races. The majority of the glob …
This year at the 17th Annual Dermatology, Aesthetic & Surgical Conference (ODAC), Dr Amy McMichael presented the audience with new pearls of advice on how to approach and diagnose complex medical dermatology cases in patients with skin of color. During her session, she addressed the important need for providers to be able to recognize disease in patients of all races. The majority of the glob … Continue reading "Challenging Cases in Skin of Color Patients"
Sprinkled with many clinical pearls, Dr. Candrice Heath gave us an informative, case-based lecture at the 2021 Skin of Color Update: “Skin Conditions Disproportionately Affecting Pediatric & Adolescent Patients with Skin of Color.” Dr. Heath is an Assistant Professor and Director of Pediatric Dermatology at Lewis Katz School of Medicine at Temple University and is active on social media @D … 
Pigmentary change often drives patients to seek dermatologic care, yet sometimes the cause is more than skin deep. Next Steps in Derm, in partnership with Skin of Color Update, interviewed conference co-chair Dr. Andrew F. Alexis about the skin signs of systemic disease in patients with darker skin tones. Watch as Dr. Alexis shares stories of the diseases he’s diagnosed in clinical practice. Le … 
Imaging is a mainstay of inpatient diagnostics. X-ray, MRI and CT scans are used to diagnose everything from broken bones to cancer. Yet these same imaging modalities are often ordered by hospitalists to diagnose dermatologic conditions even though the findings aren’t typically helpful in making an accurate diagnosis. These unnecessary tests are costly, delay an accurate diagnosis, and can add e … 
The past 18 months has seen an unprecedented wave of FDA approvals in dermatology, significantly expanding the therapeutic options for treatment of inflammatory skin diseases. At the 2025 Skin Of Color Update in New York City, conference co-chair Dr. Andrew Alexis highlighted some of these new medications and new indications for others. Importantly, many of these pivotal clinical trials includ …